IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Baker Bros. Advisors LP

Q1 2026 Holdings

Filed 2026-05-15 | 84 holdings | $17.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Incyte Corporation(INCY)COM45337C102$2.9B30,744,41216.6%
BeOne Medicines Ltd.(ONC)SPONSORED ADS07725L102$2.6B8,799,05315.0%
Insmed Incorporated(INSM)COM PAR $.01457669307$1.2B7,421,1117.0%
Madrigal Pharmaceuticals, Inc.(MDGL)COM558868105$1.1B2,141,7016.4%
Acadia Pharmaceuticals Inc.(ACAD)COM004225108$954.9M42,896,6905.5%
Revolution Medicines, Inc.(RVMD)COM76155X100$929.3M9,555,3575.3%
Celcuity Inc.(CELC)COM15102K100$903.5M7,915,7925.2%
Kodiak Sciences Inc.(KOD)COM50015M109$759.3M19,919,1864.4%
Kymera Therapeutics, Inc.(KYMR)COM501575104$721.1M8,657,2424.1%
Summit Therapeutics Inc.(SMMT)COM86627T108$690.0M36,391,0634.0%
Praxis Precision Medicines, Inc.(PRAX)COM74006W207$564.9M1,753,1983.2%
Rhythm Pharmaceuticals, Inc.(RYTM)COM76243J105$487.4M5,604,4832.8%
Alkermes plc(ALKS)SHSG01767105$354.0M10,012,2672.0%
Grail, Inc.(GRAL)COM384747101$208.2M4,028,6141.2%
Edgewise Therapeutics, Inc.(EWTX)COM28036F105$207.1M6,575,9401.2%
Ionis Pharmaceuticals, Inc.(IONS)COM462222100$153.8M2,047,7270.9%
Kiniksa Pharmaceuticals International, plc(KNSA)ORD SHS CL AG52694109$136.1M2,826,2460.8%
Immunovant, Inc.(IMVT)COM45258J102$135.6M5,457,8810.8%
Roivant Sciences Ltd.(ROIV)SHSG76279101$134.8M4,867,7230.8%
Ideaya Biosciences, Inc.(IDYA)COM45166A102$131.5M3,946,5150.8%
Arrowhead Pharmaceuticals, Inc.(ARWR)COM04280A100$124.9M1,992,7830.7%
Stoke Therapeutics, Inc.(STOK)COM86150R107$108.6M3,336,6970.6%
Immatics N.V.(IMTX)SHSN44445109$107.4M10,916,6930.6%
AbCellera Biologics Inc.(ABCL)COM00288U106$105.7M30,275,9380.6%
Abivax S.A.(ABVX)SPONSORED ADS00370M103$97.5M875,7960.6%
Crinetics Pharmaceuticals, Inc.(CRNX)COM22663K107$85.4M2,351,4650.5%
Replimune Group, Inc.(REPL)COM76029N106$84.5M11,045,3360.5%
Celcuity Inc.Note 2.75% 8/1/203115102KAA8$74.9M30,750,0000.4%
Nurix Therapeutics, Inc.(NRIX)COM67080M103$72.2M4,658,5560.4%
Denali Therapeutics Inc.(DNLI)COM24823R105$71.6M3,731,6950.4%
Dianthus Therapeutics, Inc.(DNTH)COM252828108$71.5M852,1640.4%
Monte Rosa Therapeutics, Inc.(GLUE)COM61225M102$71.5M4,345,7360.4%
Structure Therapeutics Inc.(GPCR)SPONSORED ADS86366E106$69.0M1,432,5290.4%
Entrada Therapeutics, Inc.(TRDA)COM29384C108$64.0M5,072,7300.4%
Bicycle Therapeutics plc(BCYC)SPONSORED ADS088786108$50.5M10,885,3570.3%
Spyre Therapeutics, Inc.(SYRE)COM00773J202$50.4M1,000,0000.3%
Rapport Therapeutics, Inc.(RAPP)COM75383L102$48.4M1,547,0900.3%
Alumis Inc.(ALMS)COM022307102$44.3M2,012,5000.3%
Mirum Pharmaceuticals, Inc.(MIRM)COM604749101$41.2M445,9750.2%
Viridian Therapeutics, Inc.(VRDN)COM92790C104$38.6M1,971,6780.2%
Enliven Therapeutics, Inc.(ELVN)COM29337E102$35.5M905,1910.2%
Prelude Therapeutics Inc.(PRLD)COM74065P101$34.6M10,123,8240.2%
DBV Technologies S.A.(DBVT)SPONSORED ADS23306J309$30.5M1,461,4250.2%
Design Therapeutics, Inc.(DSGN)COM25056L103$27.5M2,585,9780.2%
Centessa Pharmaceuticals plc(CNTA)SPONSORED ADS152309100$26.6M670,7510.2%
CytomX Therapeutics, Inc.(CTMX)COM23284F105$23.4M4,975,8260.1%
Jade Biosciences, Inc.(JBIO)COM008064206$23.1M1,641,1370.1%
Disc Medicine, Inc.(IRON)COM254604101$22.4M349,6570.1%
Immunocore Holdings plc(IMCR)ADS45258D105$22.1M734,3970.1%
Xenon Pharmaceuticals Inc.(XENE)COM98420N105$21.5M370,2080.1%
Page 1 of 2Next